Indegene

568.40
-6.25
(-1.09%)
ann
There are 4 new updates from the company14 hours ago
Viewcross
right
Market Cap
13,789.00 Cr
EPS
17.15
PE Ratio
32.80
Dividend Yield
0.35 %
Industry
Healthcare
52 Week High
736.30
52 Week Low
499.00
PB Ratio
5.22
Debt to Equity
0.15
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from4 analysts
HOLD
Analysts have suggested that investors can hold this stock
Buy
Buy+25.00 %
+25.00 %
Hold
Hold+50.00 %
+50.00 %
Sell
Sell+25.00 %
+25.00 %
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
642.65
#1 25,991.80
54.88
#1 3,579.20
9.66
#1 510
-2.81
47.51
568.40
#2 13,789.00
#2 32.80
#2 2,946.50
#3 10.53
#2 407
#4 24.05
42.83
240.69
5,233.10
-
32.80
#1 49.09
-105
-65.66
59.21
438.20
2,013.40
#1 32.12
322.30
0.22
41
112.87
33.69
76.08
178.60
-
769.70
-22.39
-59
#1 133.33
46.61
8.55
128.00
171.00
67.20
-65.97
-120
95.57
45.58
39.39
60.90
492.38
40.30
8.04
-1
-85.71
49.48
18.00
26.30
33.09
80.00
-3.26
2
-75.00
46.55
27.79
17.50
-
9.80
40.00
-9
-450.00
67.38
Forecast
Actual
Growth Rate
Revenue Growth
10.53 %
Net Income Growth
20.79 %
Cash Flow Change
-12.96 %
ROE
-34.00 %
ROCE
-22.58 %
EBITDA Margin (Avg.)
-0.23 %

Quarterly Financial Results

Quarterly Financials
Jun 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Revenue
540
645
636
647
687
699
699
708
758
781
Expenses
413
535
511
515
525
534
548
561
589
608
EBITDA
127
111
125
133
162
164
151
148
170
173
Operating Profit %
21 %
15 %
16 %
19 %
22 %
21 %
19 %
18 %
18 %
20 %
Depreciation
10
20
20
20
18
19
20
19
20
21
Interest
2
12
13
12
12
12
12
4
3
3
Profit Before Tax
115
79
93
101
132
134
120
124
146
149
Tax
29
30
24
26
34
39
32
32
37
32
Net Profit
86
49
68
75
99
95
88
92
110
118
EPS in ₹
3.88
2.20
3.09
3.38
4.45
4.27
3.79
3.84
4.59
4.91

Balance Sheet

Balance Sheet
2019
2020
2021
2022
2023
2024
2025
Total Assets
329
600
596
1,354
2,204
2,546
3,326
Fixed Assets
104
119
86
138
664
646
678
Current Assets
185
418
459
1,130
1,449
1,791
2,530
Capital Work in Progress
0
0
0
0
0
0
4
Investments
0
13
0
120
614
797
1,290
Other Assets
225
468
510
1,096
926
1,103
1,355
Total Liabilities
329
600
596
1,354
2,204
2,546
3,326
Current Liabilities
158
247
199
440
489
611
565
Non Current Liabilities
18
369
64
149
651
506
146
Total Equity
152
-16
333
764
1,064
1,429
2,616
Reserve & Surplus
73
-105
324
764
1,020
1,385
2,567
Share Capital
79
0
0
0
44
44
48

Cash Flow

Cash Flow
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
25
143
-41
373
-433
115
52
Investing Activities
-18
-16
-81
-158
-896
-327
-677
Operating Activities
65
22
172
297
130
508
442
Financing Activities
-21
136
-132
234
333
-66
288

Share Holding

% Holding
Dec 2022
Mar 2024
Apr 2024
May 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Promoter
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
FIIs
0.00 %
3.56 %
0.00 %
0.00 %
3.79 %
4.82 %
5.03 %
5.24 %
DIIs
0.00 %
5.33 %
0.00 %
0.00 %
3.84 %
3.17 %
3.98 %
4.96 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
11.38 %
0.00 %
0.00 %
24.67 %
24.32 %
26.41 %
11.34 %
Others
100.00 %
79.73 %
100.00 %
100.00 %
67.70 %
67.69 %
64.58 %
78.45 %
No of Share Holders
44
4,43,785
82
82
2,03,599
1,51,440
1,53,789
1,44,708

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 2
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.35

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
26 Jun 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
26 Jun 2025 609.15 580.55
13 Jun 2025 DIVIDEND Dividend
₹ 2.00 /share
13 Jun 2025 567.40 598.55
28 Apr 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
28 Apr 2025 570.25 567.40
30 Jan 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
30 Jan 2025 663.05 622.10
28 Oct 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
28 Oct 2024 653.25 675.45
06 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
06 Sept 2024 554.85 608.85
17 Nov 2022 CHANGE OF NAME Change Of Name
NA
17 Nov 2022 0.00 0.00

Announcements

Shareholder Meeting / Postal Ballot-Scrutinizers Report14 hours ago
Shareholder Meeting / Postal Ballot-Outcome of AGM14 hours ago
Shareholder Meeting / Postal Ballot-Outcome of AGM14 hours ago
Closure of Trading Window23 hours ago
Shareholder Meeting / Postal Ballot-Outcome of AGM1 day ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 16, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jun 09, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jun 06, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jun 05, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 03, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 31, 2025
Letter To Non-Email Members Providing Web Link Of Annual Report For FY 2024-25.May 30, 2025
Business Responsibility and Sustainability Reporting (BRSR)May 30, 2025
Annual Report For FY 2024-25 And Notice Of The 27Th Annual General MeetingMay 30, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 29, 2025
Announcement under Regulation 30 (LODR)-Change in DirectorateMay 27, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSMay 27, 2025
Record Date For The Purpose Of DividendMay 27, 2025
Intimation Of Outcome Of Board MeetingMay 27, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 26, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 22, 2025
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Change In Corporate Identity Number (CIN)May 20, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 19, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 06, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 02, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationApr 30, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeApr 29, 2025
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportApr 28, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationApr 28, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseApr 28, 2025
Announcement under Regulation 30 (LODR)-Dividend UpdatesApr 28, 2025
Board Meeting Outcome for Intimation Of Outcome Of Board MeetingApr 28, 2025
Change In Contact Details Of MUFG Intime India Private Limited Registrar And Transfer Agent Of The Company.Apr 24, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSApr 21, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationApr 21, 2025
Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Apr 21, 2025
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportApr 18, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 15, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 30, 2025
Closure of Trading WindowMar 27, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationMar 26, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 26, 2025
Corrective Action On NSE LetterMar 26, 2025
Announcement under Regulation 30 (LODR)-AcquisitionMar 25, 2025
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Mar 19, 2025
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Mar 19, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMar 19, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 18, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMar 18, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMar 18, 2025

Technical Indicators

RSI(14)
Neutral
42.83
ATR(14)
Less Volatile
17.70
STOCH(9,6)
Neutral
21.28
STOCH RSI(14)
Oversold
13.93
MACD(12,26)
Bearish
-2.89
ADX(14)
Weak Trend
12.70
UO(9)
Bearish
41.41
ROC(12)
Downtrend And Accelerating
-6.33
WillR(14)
Oversold
-92.67

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Baroda BNP Paribas Flexi Cap Fund Direct - Growth
1.31%
-74750
-0.26%
-0.40%
Navi Aggressive Hybrid Fund Direct - Growth
1.46%
7739
0.43%
0.38%
Nippon India Nifty Smallcap 250 Index Fund Direct - Growth
0.30%
2236
0.01%
-0.02%
SBI Nifty Smallcap 250 Index Fund Direct - Growth
0.30%
1338
0.00%
-0.02%
Motilal Oswal Nifty Smallcap 250 Index Fund Direct - Growth
0.30%
942
0.00%
-0.02%
HDFC Nifty Smallcap 250 Index Fund Direct-Growth
0.30%
605
0.00%
-0.02%
Nippon India Nifty 500 Equal Weight Index Fund Direct-Growth
0.19%
-426
0.00%
-0.02%
Motilal Oswal Nifty 500 Index Fund Direct - Growth
0.03%
385
0.00%
0.00%
Edelweiss Nifty Smallcap 250 Index Fund Direct - Growth
0.30%
270
0.00%
-0.02%
ICICI Prudential Nifty Smallcap 250 Index Fund Direct - Growth
0.30%
226
0.00%
-0.02%
Kotak Nifty Smallcap 250 Index Fund Direct-Growth
0.30%
86
0.00%
-0.02%
Groww Nifty Smallcap 250 Index Fund Direct - Growth
0.30%
84
0.00%
-0.02%
Axis Nifty 500 Index Fund Direct-Growth
0.03%
-77
0.00%
0.00%
Navi Nifty 500 Multicap 50:25:25 Index Fund Direct-Growth
0.08%
32
0.01%
0.01%
HDFC Nifty500 Multicap 50:25:25 Index Fund Direct-Growth
0.08%
22
0.01%
0.00%
Groww Nifty Total Market Index Fund Direct - Growth
0.03%
17
0.00%
0.00%
SBI Nifty 500 Index Fund Direct-Growth
0.03%
-14
0.00%
0.00%
Angel One Nifty Total Market Index Fund Direct - Growth
0.03%
11
0.00%
0.00%
ICICI Prudential Nifty 500 Index Fund Direct-Growth
0.03%
11
0.00%
0.00%
Mirae Asset Nifty Total Market Index Fund Direct-Growth
0.03%
5
0.00%
0.00%
Bandhan Nifty Smallcap 250 Index Fund Direct-Growth
0.30%
-3
0.01%
-0.02%
Bandhan BSE Healthcare Index Fund Direct-Growth
0.36%
2
0.03%
0.00%
Bandhan Nifty Total Market Index Fund Direct-Growth
0.03%
2
0.00%
0.00%
Helios Balanced Advantage Fund Direct - Growth
1.17%
0
0.09%
0.00%
WhiteOak Capital Pharma and Healthcare Fund Direct - Growth
0.00%
0
0.00%
0.00%

About Indegene

Indegene Limited is a global provider of digital-led commercialization services for the life sciences industry. The company offers solutions in analytics, technology, and commercial, medical, regulatory, and safety services to biopharmaceutical, emerging biotech, and medical devices companies. Indegene operates through four main segments: Enterprise Commercial Solutions, Omnichannel Activation, Enterprise Medical Solutions, and Others. These segments assist with digital marketing operations, last-mile promotion optimization, regulatory and medical operations consolidation, and clinical solutions and consultancy services. The company has made several acquisitions to expand its capabilities, including Encima Group, DT Associates, Cult Health, and Trilogy Writing & Consulting GmbH. In 2023, Indegene launched Invisage, an AI-enabled hybrid omnichannel sales and marketing platform. The company completed a public issue in May 2024, raising funds through a fresh issue and offer for sale.
Listing Date
13 May, 2024(1 Years, 15 days)
Chairperson NameManish Gupta
OSZAR »